Testing a risk assessment to predict prostate cancer on biopsy
Part of Cancer, Kidney & urinary clinical trials.
This trial studies whether a risk assessment can better predict who actually has prostate cancer based on information collected around the biopsy. It may help doctors decide what biopsy findings mean for people with certain PSA (a blood test) results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be having a prostate biopsy to look for prostate cancer (not for follow-up of known cancer)
- Be between 40 and 69 years old
- Your PSA blood test must be between 2.5 and 10 ng/mL
- Your ethnicity must match one of these groups: Caucasian, African American, East Asian, or Latino (mixed ethnicity may not qualify)
- You must not have had a past diagnosis of prostate cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how inherited risk (family history or gene findings) relates to screening and treatment for prostate cancer. If you qualify, you may be offered prostate screening tests and follow-up to see how well risk information predicts next steps.
This study looks at your personal and family risk for prostate cancer and helps decide who should have extra screening like MRI. It may help you find cancer earlier if you are at higher genetic risk.
This study uses a genetic risk score and a special MRI scan to find prostate cancers that are more likely to be dangerous. It aims to see if combining these tests can better identify which men need a biopsy.
This study tests a new blood test (PRODICT®) to see how well it works for finding prostate cancer in men from different ethnic backgrounds. It aims to make sure the test is accurate and fair for everyone.
This study looks at how patients and doctors feel about genetic testing for prostate cancer. It aims to improve how genetic risk information is shared and understood.
This trial studies a blood test that looks for tumor DNA in men with high-risk or advanced prostate cancer. It may help doctors understand the cancer better and guide treatment decisions.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.